BC subtypes are diagnosed by the presence or absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), and tumors that lack all three receptors are triple-negative BC (TNBC) [2]. Here, ERBB2 is linked to breast cancer.